If MYC-driven DNA damage and cellular senescence occur also as a consequence of other mitochondrial disease mutations than those causing severe CIII deficiency, understanding the role of MYC could enable several novel therapeutic options. The gene discussed is MYC; the disease is inborn mitochondrial metabolism disorder.